Systemic sclerosis

ER Volkmann, K Andréasson, V Smith - The Lancet, 2023 - thelancet.com
Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune
connective-tissue disease. Once considered an untreatable and unpredictable condition …

Inflammation and DNA damage: cause, effect or both

A Pezone, F Olivieri, MV Napoli, A Procopio… - Nature Reviews …, 2023 - nature.com
Inflammation is a biological response involving immune cells, blood vessels and mediators
induced by endogenous and exogenous stimuli, such as pathogens, damaged cells or …

[HTML][HTML] Current advances in the treatment of systemic sclerosis

H Bukiri, ER Volkmann - Current opinion in pharmacology, 2022 - Elsevier
Systemic sclerosis (SSc) is a rare, systemic autoimmune disease of unknown etiology.
Among the systemic rheumatic diseases, SSc carries the highest mortality, in part due to the …

[HTML][HTML] Endothelial dysfunction in systemic sclerosis

E Patnaik, M Lyons, K Tran, D Pattanaik - International Journal of …, 2023 - mdpi.com
Systemic sclerosis, commonly known as scleroderma, is an autoimmune disorder
characterized by vascular abnormalities, autoimmunity, and multiorgan fibrosis. The exact …

[HTML][HTML] When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis

R Akbarzadeh, A Müller, JY Humrich… - Frontiers in …, 2023 - frontiersin.org
Systemic sclerosis (SSc) is a chronic, multisystem connective tissue, and autoimmune
disease with the highest case-specific mortality and complications among rheumatic …

[HTML][HTML] Genomic instability in early systemic sclerosis

R Gniadecki, A Iyer, D Hennessey, L Khan… - Journal of …, 2022 - Elsevier
Abstract Objectives Systemic sclerosis (SSc) is associated with secondary malignancies.
Previous studies have suggested that mutated cancer proteins, such as RNA polymerase III …

[HTML][HTML] Decreased serum levels of SIRT1 and SIRT3 correlate with severity of skin and lung fibrosis and peripheral microvasculopathy in systemic sclerosis

M Manetti, I Rosa, BS Fioretto… - Journal of Clinical …, 2022 - mdpi.com
Systemic sclerosis (SSc, scleroderma) is a severe autoimmune connective tissue disease
characterized by widespread peripheral microvasculopathy, and progressive cutaneous and …

[HTML][HTML] Protein profiling in systemic sclerosis patients with different pulmonary complications using proteomic antibody microarray

J Huang, H Zhu, S Liu, M Li, Y Li, H Luo… - Arthritis Research & …, 2024 - Springer
Background Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) are
leading causes of systemic sclerosis (SSc)-related death. In this study, we aimed to identify …

[HTML][HTML] The involvement of smooth muscle, striated muscle, and the myocardium in Scleroderma: a review

I Bratoiu, AM Burlui, A Cardoneanu… - International Journal of …, 2022 - mdpi.com
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by heterogeneous
changes involving numerous organs and systems. The currently available data indicate that …

[HTML][HTML] Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

M Kerick, M Acosta-Herrera, CP Simeón-Aznar… - NPJ genomic …, 2022 - nature.com
Copy number (CN) polymorphisms of complement C4 play distinct roles in many conditions,
including immune-mediated diseases. We investigated the association of C4 CN with …